PAQR4 regulates adipocyte function and systemic metabolic health by mediating ceramide levels
Zhu, Q. & Scherer, P. E. Immunologic and endocrine functions of adipose tissue: implications for kidney disease. Nat. Rev. Nephrol. 14, 105–120 (2018).
Google Scholar
Zhu, Q., An, Y. A. & Scherer, P. E. Mitochondrial regulation and white adipose tissue homeostasis. Trends Cell Biol. 32, 351–364 (2022).
Google Scholar
Wang, Q. A. et al. Reversible de-differentiation of mature white adipocytes into preadipocyte-like precursors during lactation. Cell Metab. 28, 282–288.e3 (2018).
Google Scholar
Zhang, Z. et al. Dermal adipose tissue has high plasticity and undergoes reversible dedifferentiation in mice. J. Clin. Invest. 129, 5327–5342 (2019).
Google Scholar
Shook, B. A. et al. Dermal adipocyte lipolysis and myofibroblast conversion are required for efficient skin repair. Cell Stem Cell 26, 880–895.e6 (2020).
Google Scholar
Bi, P. et al. Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. J. Exp. Med. 213, 2019–2037 (2016).
Google Scholar
Liu, S. C. et al. Epstein–Barr virus induces adipocyte dedifferentiation to modulate the tumor microenvironment. Cancer Res. 81, 3283–3294 (2021).
Google Scholar
Zhu, Q. et al. Adipocyte mesenchymal transition contributes to mammary tumor progression. Cell Rep. 40, 111362 (2022).
Google Scholar
Chaurasia, B. et al. Adipocyte ceramides regulate subcutaneous adipose browning, inflammation, and metabolism. Cell Metab. 24, 820–834 (2016).
Google Scholar
Scherer, P. E. The many secret lives of adipocytes: implications for diabetes. Diabetologia 62, 223–232 (2019).
Google Scholar
Turpin-Nolan, S. M. & Brüning, J. C. The role of ceramides in metabolic disorders: when size and localization matters. Nat. Rev. Endocrinol. 16, 224–233 (2020).
Google Scholar
Chaurasia, B. et al. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. Science 365, 386–392 (2019).
Google Scholar
Kupchak, B. R., Garitaonandia, I., Villa, N. Y., Smith, J. L. & Lyons, T. J. Antagonism of human adiponectin receptors and their membrane progesterone receptor paralogs by TNFα and a ceramidase inhibitor. Biochemistry 48, 5504–5506 (2009).
Google Scholar
Tang, Y. T. et al. PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J. Mol. Evol. 61, 372–380 (2005).
Google Scholar
Yamauchi, T., Iwabu, M., Okada-iwabu, M. & Kadowaki, T. Adiponectin receptors: a review of their structure, function and how they work. Best. Pract. Res. Clin. Endocrinol. Metab. 28, 15–23 (2014).
Google Scholar
Holland, W. L. et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17, 55–63 (2011).
Google Scholar
Garitaonandia, I., Smith, J. L., Kupchak, B. R. & Lyons, T. J. Adiponectin identified as an agonist for PAQR3/RKTG using a yeast-based assay system. J. Recept. Signal Transduct. 29, 67–73 (2009).
Google Scholar
Pedersen, L. et al. Golgi-localized PAQR4 mediates antiapoptotic ceramidase activity in breast cancer. Cancer Res. 80, 2163–2174 (2020).
Google Scholar
Xu, D. et al. PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus. Nat. Commun. 6, 8100 (2015).
Google Scholar
Jiang, Y. et al. Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition. Cancer Res. 71, 2959–2968 (2011).
Google Scholar
Yu, X., Li, Z., Chan, M. T. V. & Wu, W. K. K. PAQR3: a novel tumor suppressor gene. Am. J. Cancer Res. 5, 2562–2568 (2015).
Google Scholar
Zhang, H. et al. PAQR4 has a tumorigenic effect in human breast cancers in association with reduced CDK4 degradation. Carcinogenesis 39, 439–446 (2018).
Google Scholar
Okada-Iwabu, M. et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 503, 493–499 (2013).
Google Scholar
Beals, J. W. et al. Increased adipose tissue fibrogenesis, not impaired expandability, is associated with nonalcoholic fatty liver disease. Hepatology 74, 1287–1299 (2021).
Google Scholar
Kusminski, C. M. et al. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat. Med. 18, 1539–1551 (2012).
Google Scholar
An, Y. A. et al. The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysis. J. Hepatol. 75, 387–399 (2021).
Google Scholar
Ferrero, R., Rainer, P. & Deplancke, B. Toward a consensus view of mammalian adipocyte stem and progenitor cell heterogeneity. Trends Cell Biol. 30, 937–950 (2020).
Google Scholar
Burl, R. B. et al. Deconstructing adipogenesis induced by β3-adrenergic receptor activation with single-cell expression profiling. Cell Metab. 28, 300–309.e4 (2018).
Google Scholar
Merrick, D. et al. Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science 364, aav2501 (2019).
Schwalie, P. C. et al. A stromal cell population that inhibits adipogenesis in mammalian fat depots. Nature 559, 103–108 (2018).
Google Scholar
Shao, M. et al. Pathologic HIF1α signaling drives adipose progenitor dysfunction in obesity. Cell Stem Cell 28, 685–701.e7 (2021).
Google Scholar
Wang, Q. A., Tao, C., Gupta, R. K. & Scherer, P. E. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat. Med. 19, 1338–1344 (2013).
Google Scholar
Ussher, J. R. et al. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 59, 2453–2464 (2010).
Google Scholar
Amrutkar, M. et al. Genetic disruption of protein kinase STK25 ameliorates metabolic defects in a diet-induced type 2 diabetes model. Diabetes 64, 2791–2804 (2015).
Google Scholar
Guerre-Millo, M. et al. PPAR-α-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50, 2809–2814 (2001).
Google Scholar
Xia, J. Y. et al. Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis. Cell Metab. 22, 266–278 (2015).
Google Scholar
Ogretmen, B. Sphingolipid metabolism in cancer signalling and therapy. Nat. Rev. Cancer 18, 33–50 (2017).
Google Scholar
Spalding, K. L. et al. Dynamics of fat cell turnover in humans. Nature 453, 783–787 (2008).
Google Scholar
Ghaben, A. L. & Scherer, P. E. Adipogenesis and metabolic health. Nat. Rev. Mol. Cell Biol. 20, 242–258 (2019).
Google Scholar
Sprott, K. M., Chumley, M. J., Hanson, J. M. & Dobrowsky, R. T. Decreased activity and enhanced nuclear export of CCAAT-enhancer-binding protein β during inhibition of adipogenesis by ceramide. Biochem. J. 365, 181–191 (2002).
Google Scholar
Jones, J. E. C. et al. The adipocyte acquires a fibroblast-like transcriptional signature in response to a high fat diet. Sci. Rep. 10, 1–15 (2020).
Roh, H. C. et al. Adipocytes fail to maintain cellular identity during obesity due to reduced PPARγ activity and elevated TGFβ-SMAD signaling. Mol. Metab. 42, 101086 (2020).
Google Scholar
Kruglikov, I. L. & Scherer, P. E. Dermal adipocytes: from irrelevance to metabolic targets? Trends Endocrinol. Metab. 27, 1–10 (2016).
Google Scholar
Shan, B. et al. Perivascular mesenchymal cells control adipose-tissue macrophage accrual in obesity. Nat. Metab. 2, 1332–1349 (2020).
Google Scholar
Laviad, E. L., Kellys, S., Merrill, A. H. & Futerman, A. H. Modulation of ceramide synthase activity via dimerization. J. Biol. Chem. 287, 21025–21033 (2012).
Google Scholar
Hammerschmidt, P. et al. CerS6-derived sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity. Cell 177, 1536–1552.e23 (2019).
Google Scholar
Raichur, S. et al. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab. 20, 687–695 (2014).
Google Scholar
Rodriguez-Cuenca, S., Pellegrinelli, V., Campbell, M., Oresic, M. & Vidal-Puig, A. Sphingolipids and glycerophospholipids – The ‘ying and yang’ of lipotoxicity in metabolic diseases. Prog. Lipid Res. 66, 14–29 (2017).
Google Scholar
Volkmar, N. et al. Regulation of membrane fluidity by RNF145 ‐triggered degradation of the lipid hydrolase ADIPOR2. EMBO J. 41, 1–22 (2022).
Wang, K. et al. Pan-cancer analysis of the prognostic and immunological role of PAQR4. Sci. Rep. 12, 1–16 (2022).
Brachtendorf, S., El-Hindi, K. & Grösch, S. Ceramide synthases in cancer therapy and chemoresistance. Prog. Lipid Res. 74, 160–185 (2019).
Google Scholar
Morad, S. A. F. & Cabot, M. C. Ceramide-orchestrated signalling in cancer cells. Nat. Rev. Cancer 13, 51–65 (2013).
Google Scholar
Li, Y. et al. Ceramides increase fatty acid utilization in intestinal progenitors to enhance stemness and increase tumor risk. Gastroenterology 165, 1136–1150 (2023).
Google Scholar
Zhang, Y. et al. C24-ceramide drives gallbladder cancer progression through directly targeting phosphatidylinositol 5-phosphate 4-kinase type-2 γ to facilitate mammalian target of rapamycin signaling activation. Hepatology 73, 692–712 (2021).
Google Scholar
Dany, M. & Ogretmen, B. Ceramide induced mitophagy and tumor suppression. Biochim. Biophys. Acta Mol. Cell Res. 1853, 2834–2845 (2015).
Google Scholar
Inoue, T. et al. Mechanistic insights into the hydrolysis and synthesis of ceramide by neutral ceramidase. J. Biol. Chem. 284, 9566–9577 (2009).
Google Scholar
Okino, N. et al. The reverse activity of human acid ceramidase. J. Biol. Chem. 278, 29948–29953 (2003).
Google Scholar
El Bawab, S. et al. Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase. J. Biol. Chem. 276, 16758–16766 (2001).
Google Scholar
Zhu, Q. et al. Suppressing adipocyte inflammation promotes insulin resistance in mice. Mol. Metab. 39, 1–11 (2020).
Deng, Y. et al. Adipocyte Xbp1s overexpression drives uridine production and reduces obesity. Mol. Metab. 11, 1–17 (2018).
Google Scholar
Zhang, Z. et al. Adipocyte iron levels impinge on a fat-gut crosstalk to regulate intestinal lipid absorption and mediate protection from obesity. Cell Metab. 33, 1624–1639.e9 (2021).
Google Scholar
Zhu, Q. et al. Adipocyte-specific deletion of Ip6k1 reduces diet-induced obesity by enhancing AMPK-mediated thermogenesis. J. Clin. Invest. 126, 4273–4288 (2016).
Google Scholar
Zhang, Z. et al. Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in mice. Proc. Natl Acad. Sci. USA 113, E6418–E6426 (2016).
Google Scholar
Kusminski, C. M. et al. A novel model of diabetic complications: adipocyte mitochondrial dysfunction triggers massive β-cell hyperplasia. Diabetes 69, 313–330 (2020).
Google Scholar
Rampler, E. et al. Simultaneous non-polar and polar lipid analysis by on-line combination of HILIC, RP and high resolution MS. Analyst 143, 1250–1258 (2018).
Google Scholar
Kim, H. J., Qiao, Q., Toop, H. D., Morris, J. C. & Don, A. S. A fluorescent assay for ceramide synthase activity. J. Lipid Res. 53, 1701–1707 (2012).
Google Scholar
Tani, M., Okino, N., Mitsutake, S. & Ito, M. Specific and sensitive assay for alkaline and neutral ceramidases involving C12-NBD-ceramide. J. Biochem. 125, 746–749 (1999).
Google Scholar
Zhu, Q., Ghoshal, S., Tyagi, R. & Chakraborty, A. Global IP6K1 deletion enhances temperature modulated energy expenditure which reduces carbohydrate and fat induced weight gain. Mol. Metab. 6, 73–85 (2017).
Google Scholar
Ninagawa, S. et al. Forcible destruction of severely misfolded mammalian glycoproteins by the non-glycoprotein ERAD pathway. J. Cell Biol. 211, 775–784 (2015).
Google Scholar
link
